Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 20/02/2012
SPC Gemeprost

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   09-Feb-2012
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 1 updated with the addition of an alternative name of the medicinal product 'Cervagem 1mg Pessary'.  The existing product name has been aligned with the QRD template.
Updated on 17/09/2007 and displayed until 20/02/2012
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   10/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7 (Marketing Authorisation Holder): change to MA Holder's address
Updated on 17/08/2006 and displayed until 17/09/2007
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   09/2005
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change to date in section 10
Updated on 14/03/2006 and displayed until 17/08/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
Updated on 14/01/2002 and displayed until 14/03/2006
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
Updated on 16/07/2001 and displayed until 14/01/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 08/12/2000 and displayed until 16/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  gemeprost